Bernard Zinman

2.5k total citations
43 papers, 2.0k citations indexed

About

Bernard Zinman is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Bernard Zinman has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Bernard Zinman's work include Diabetes Treatment and Management (20 papers), Diabetes Management and Research (18 papers) and Metabolism, Diabetes, and Cancer (8 papers). Bernard Zinman is often cited by papers focused on Diabetes Treatment and Management (20 papers), Diabetes Management and Research (18 papers) and Metabolism, Diabetes, and Cancer (8 papers). Bernard Zinman collaborates with scholars based in Canada, United States and Germany. Bernard Zinman's co-authors include Anthony J. Hanley, Angela M. Cheung, Warren L. Lee, Stewart B. Harris, Hertzel C. Gerstein, Thomas M.S. Wolever, Joel Gittelsohn, Janice Pogue, Salim Yusuf and Brit I. Saksvig and has published in prestigious journals such as Circulation, Annals of Internal Medicine and American Journal of Clinical Nutrition.

In The Last Decade

Bernard Zinman

39 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Zinman Canada 18 878 410 369 345 301 43 2.0k
K.‐T. Khaw United Kingdom 20 706 0.8× 352 0.9× 199 0.5× 338 1.0× 262 0.9× 35 2.0k
Carlos Posadas‐Romero Mexico 25 648 0.7× 498 1.2× 326 0.9× 412 1.2× 273 0.9× 129 2.2k
George Alberti United Kingdom 17 763 0.9× 300 0.7× 259 0.7× 201 0.6× 300 1.0× 21 1.9k
Bisher Kawar United Kingdom 9 534 0.6× 256 0.6× 326 0.9× 267 0.8× 395 1.3× 13 2.0k
Femmie de Vegt Netherlands 22 1.3k 1.5× 386 0.9× 433 1.2× 217 0.6× 293 1.0× 37 2.5k
Seung-Hyun Ko South Korea 16 1.1k 1.2× 340 0.8× 371 1.0× 473 1.4× 375 1.2× 37 2.4k
Srikanth Bellary United Kingdom 23 1.1k 1.3× 323 0.8× 405 1.1× 384 1.1× 309 1.0× 85 2.6k
Philip A Morales United States 15 1.1k 1.3× 452 1.1× 216 0.6× 337 1.0× 333 1.1× 20 1.8k
Rocco Galasso Italy 25 598 0.7× 257 0.6× 416 1.1× 826 2.4× 486 1.6× 60 2.4k
Z Fuchs Israel 14 888 1.0× 524 1.3× 269 0.7× 197 0.6× 249 0.8× 20 1.9k

Countries citing papers authored by Bernard Zinman

Since Specialization
Citations

This map shows the geographic impact of Bernard Zinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Zinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Zinman more than expected).

Fields of papers citing papers by Bernard Zinman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Zinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Zinman. The network helps show where Bernard Zinman may publish in the future.

Co-authorship network of co-authors of Bernard Zinman

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Zinman. A scholar is included among the top collaborators of Bernard Zinman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Zinman. Bernard Zinman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanley, Anthony J., et al.. (2024). Sustained Reduction of Subclinical Inflammation in the Years After Breastfeeding. The Journal of Clinical Endocrinology & Metabolism. 110(7). e2208–e2216.
2.
Heerspink, Hiddo J.L., George L. Bakris, David M. Charytan, et al.. (2020). 27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease. Diabetes. 69(Supplement_1). 1 indexed citations
3.
4.
Brown‐Frandsen, Kirstine, Scott S. Emerson, Steven P. Marso, et al.. (2018). Rates of Major Adverse Cardiovascular (CV) Events (MACE) and Mortality with Basal Insulin by Liraglutide Use—A DEVOTE Subanalysis. Diabetes. 67(Supplement_1).
5.
Pfarr, Egon, et al.. (2017). Effect of Empagliflozin on Albuminuria in Patients with Type 2 Diabetes and High Cardiovascular Risk. 59(3). 376. 1 indexed citations
6.
Mentz, Robert J., M. Angelyn Bethel, Vivian P. Thompson, et al.. (2017). Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial. Circulation. 136. 1 indexed citations
7.
Leiter, Lawrence A., Bernard Zinman, Steven P. Marso, et al.. (2017). Severe Hypoglycemia, Cardiovascular Outcomes and Death in LEADER. Canadian Journal of Diabetes. 41(5). S68–S68. 1 indexed citations
8.
Heller, Simon, Chantal Mathieu, Rahul Kapur, Michael Lyng Wolden, & Bernard Zinman. (2015). Nocturnal confirmed hypoglycaemia with insulin degludec vs insulin glargine: rate ratios for different definitions. Lirias (KU Leuven).
9.
Zinman, Bernard, et al.. (2013). Achieving fasting plasma glucose target without nocturnal hypoglycaemia: a pooled analysis of studies in type 2 diabetes comparing insulin degludec vs insulin glargine. Diabetologia. 56. 1 indexed citations
10.
Rodbard, Helena W., Bernard Zinman, Bertrand Cariou, et al.. (2012). Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes. Diabetologia. 55. 2 indexed citations
11.
Zinman, Bernard, J. E. Gerich, John B. Buse, et al.. (2010). Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230)). Diabetes Care. 33(3). 240 indexed citations
12.
Nathan, David M., John B. Buse, Mayer B. Davidson, et al.. (2006). Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy (vol 49, pg 2816, 2006). Diabetologia. 49. 2816–2818. 4 indexed citations
13.
Ross, S., et al.. (2001). A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.. PubMed. 24(6). 292–8. 56 indexed citations
14.
Hanley, Anthony J., Stewart B. Harris, Joel Gittelsohn, et al.. (2000). Overweight among children and adolescents in a Native Canadian community: prevalence and associated factors. American Journal of Clinical Nutrition. 71(3). 693–700. 253 indexed citations
15.
Cheng, Alice, Elaine Y. L. Tsui, Anthony J. Hanley, & Bernard Zinman. (1999). Developing a quality of life measure for Chinese patients with diabetes. Diabetes Research and Clinical Practice. 46(3). 259–267. 28 indexed citations
16.
Hegele, Robert A., Stewart B. Harris, Philip W. Connelly, et al.. (1998). Genetic variation in paraoxonase‐2 is associated with variation in plasma lipoproteins in Canadian Oji‐Cree. Clinical Genetics. 54(5). 394–399. 21 indexed citations
17.
Gittelsohn, Joel, Stewart B. Harris, Anjali Sharma, et al.. (1996). Use of Ethnographic Methods for Applied Research on Diabetes Among the Ojibway-Cree in Northern Ontario. Health Education Quarterly. 23(3). 365–382. 57 indexed citations
18.
19.
Shumak, Steven L., Loren D. Grossman, V Kozousek, et al.. (1990). Growth hormone suppression and nonproliferative diabetic retinopathy: a preliminary feasibility study.. PubMed. 13(5). 287–92. 15 indexed citations
20.
Zinman, Bernard, et al.. (1982). Exercise in diabetic man: glucose turnover and free insulin responses after glycemic normalization with intravenous insulin. Canadian Journal of Physiology and Pharmacology. 60(10). 1236–1240. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.‐T. Khaw Breakdown of academic impact, for papers by Carlos Posadas‐Romero Breakdown of academic impact, for papers by George Alberti Breakdown of academic impact, for papers by Bisher Kawar Breakdown of academic impact, for papers by Femmie de Vegt Breakdown of academic impact, for papers by Seung-Hyun Ko Breakdown of academic impact, for papers by Srikanth Bellary Breakdown of academic impact, for papers by Philip A Morales Breakdown of academic impact, for papers by Rocco Galasso Breakdown of academic impact, for papers by Z Fuchs
Rankless by CCL
2026